Spring direct naar de hoofdnavigatie of de inhoud
‘Patents can work for or against you. Creating your own patent portfolio, while mitigating the risks of your competitors’ IP rights, is essential for success in today’s technology-based economy.’
Tamara Elmore

Tamara Elmore

  • Life Sciences
  • European and Dutch Patent Attorney, European Patent Litigator
  • United States Patent Agent
  • Partner

Tamara Elmore is a Dutch and European patent attorney and a United States patent agent. She started her career at a large pharmaceutical company in Switzerland, before joining an IP office in Boston as a US patent agent. In 2009, she switched to V.O. where she is active as a patent attorney in the Chemistry & Life Sciences Department.

Continue reading

One of her goals is to provide clients with the information and analysis that will enable them to make informed business decisions over complex intellectual property matters.

Tamara’s focus is on obtaining patent protection for her clients’ inventions and strategically managing their patent portfolios. Additional aspects of her practice include patent validity and infringement analysis as well as IP due diligence.

Working experience

  • Patent Attorney, V.O. (2009-present)
  • United States Patent Agent, Ropes & Gray (2006-2009)
  • European Patent Attorney trainee, Hoffman La-Roche (2005)
  • Post-doc, University of Zurich (2002 – 2004)

Education

  • Master in Intellectual Property, ETH, Zurich (2005)
  • PhD in Molecular Biology, University of Texas Southwestern (2002)
  • MSc in Zoology, Texas Tech University (1995)

Directories

  • Recognized as IP Star and ranked among the ‘Top 250 Women in IP’ (2023) by Managing Intellectual Property

Publications

  • Elmore T, Reach-through royalty provisions in licensing contracts; The Berkeley Electronic Press (bepress) 2005 http://www.bepress.com/ndsip/reports/art2
  • Elmore T, Ignell R, Carlson JR, Smith DP. Targeted mutation of a Drosophila odor receptor defines receptor requirement in a novel class of sensillum. J Neurosci. 2003 Oct 29;23(30):9906-12.
  • Elmore T, Smith DP. Putative Drosophila odor receptor OR43b localizes to dendrites of olfactory neurons. Insect Biochem Mol Biol. 2001 Jun 22;31(8):791-8.
  • Elmore T, Rodriguez A, Smith DP. dRGS7 encodes a Drosophila homolog of EGL-10 and vertebrate RGS7. DNA Cell Biol. 1998 Nov;17(11):983-9.

Languages

  • English

Also see these experts

Sjoerd Postma

Sjoerd Postma

  • European and Dutch Patent Attorney, European Patent Litigator
  • Associate
Frits Schut

Frits Schut

  • European and Dutch Patent Attorney
  • Partner
More experts

News

Leap helps high-tech companies to innovate

Technology companies need to act readily when it comes to applying – in a timely manner – for grants or funding for their innovations. Leap is an innovation consulting firm that specializes in grants, brokers funding and helps companies innovate. We spoke to Rob Luyben, business manager at Leap.Continue reading

Litigation costs in Dutch courts

There is a special provision in the law for the award of legal costs in lawsuits concerning the enforcement of intellectual property rights (IP). However, the court has sufficient room in its judgment on the award of legal costs to take into account all the circumstances of the individual case. This is demonstrated by the […]Continue reading

Successful completion of internal training

This summer ten trainees from V.O. successfully completed V.O.’s internal patent attorney training. In July, Vicky Andréka, Leen Beller, Raimondo Cau, Tamara Idema, Monika Jędrzejczyk, Martin Pekař, Matthijs Roelofs, Senne Plessers, Sara Tekavec and Lydia Schenk festively received their certificates.Continue reading

Events

Dutch Life Science Conference 2023

CORPUS Congress Centre, Willem Einthovenstraat, Oegstgeest, Netherlands

Dutch Life Sciences conference is Netherlands´ most established life sciences event. It has positioned itself as the premier annual meeting place for both Dutch and international players. The event brings together leading CEOs of biotech, pharma and medical devices companies, heads of R&D, academics, and life sciences investors from the healthcare sector for networking opportunities to promote the translation of inventions into e.g. therapies, medical devices and diagnostics distribution in and across the healthcare system.

Continue reading